Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global DNA sequencing products market size reached a value of about USD 4.6 billion in 2020. The market is further expected to grow at a CAGR of about 15% between 2021 and 2026 to reach around USD 10.6 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Researchers and developers have developed a variety of DNA sequencing technologies that provide higher precision and faster sequencing at a reduced cost. For example, Illumina, a key player, has introduced a device consisting of 10 ultra-throughput sequencers and can sequence approximately 18,000 human genomes per year. Researchers now use ground-breaking genome mapping techniques that take less time to complete. Thus, the reduction of sequencing costs has led many organisations to invest in research and development programs, providing economical approaches such as genome sequencing as a whole, novo sequencing, and the detection of particular diseases. These factors are expected to propel the growth of the DNA sequencing products market in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
DNA sequencing is the method used to measure sequences correctly in a DNA molecule, i.e. cytosine, adenine, thymine, and guanine, of the four nuclear bases. It plays a significant role in the mapping of the human genome and helps in multiple applications of scientific science. The products, thus, are gaining popularity in the pharmaceutical industry by helping researchers understand complex diseases and, in effect, by creating customised patient medicines. DNA profiling has, furthermore, become an essential part of forensic science, since these profiles enable researchers to recognise and differentiate multiple samples from a DNA pool.
On the basis of product type, the industry can be divided into the following:
It finds wide applications in the following:
The end-use sectors in the market are:
The regional markets for the products include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Microorganism genome mapping and sequencing have made it possible for farmers to use them for crops and food plants. Over the last few years, in food plants, different bacterial genes have been used to enhance their resistance to insects and pests, which has improved their production and nutritional value. Genomes from many domesticated animals, including chicken, pig, cow, sheep, and horses, were sequenced, partially or entirely, and were also shown to be useful for the development of animals with improved meat and milk quality. The role of DNA sequencing in the in-vitro diagnostics industry is expected to gain momentum, especially for point-of-care diagnostics. DNA sequencing allows the development of accurate medicine to provide patients with unique medications or therapies. This also offers numerous tools for genetic sequencing and study of DNA data with high precision and rapid diagnosis at the point of treatment. Thus, the growing adoption of the products across agricultural and medical sectors is expected to support the growth of the global DNA sequencing products market.
The report gives a detailed analysis of the following companies in the global DNA sequencing products market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Application, End Use, Region |
Breakup by Product Type | Consumables and Reagents, Equipment |
Breakup by Application | Biomarkers, Diagnostics, Reproductive Health, Forensics, Personalised Medicine, Others |
Breakup by End Use | Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., Beckman Coulter, Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global DNA Sequencing Products Market Analysis
8.1 Key Industry Highlights
8.2 Global DNA Sequencing Products Historical Market (2018-2022)
8.3 Global DNA Sequencing Products Market Forecast (2023-2028)
8.4 Global DNA Sequencing Products Market by Product Type
8.4.1 Consumables and Reagents
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Equipment
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global DNA Sequencing Products Market by Application
8.5.1 Biomarkers
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Diagnostics
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Reproductive Health
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Forensics
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Personalised Medicine
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Others
8.6 Global DNA Sequencing Products Market by End Use
8.6.1 Academic and Government Research Institutes
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Pharmaceutical and Biotechnology Companies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Hospitals and Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global DNA Sequencing Products Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players’ Market Share
12.3 Company Profiles
12.3.1 Illumina, Inc.
12.3.1.1 Company Overview
12.3.1.2 Company Description
12.3.2 Thermo Fisher Scientific Inc.
12.3.2.1 Company Overview
12.3.2.2 Company Description
12.3.3 F. Hoffmann-La Roche Ltd
12.3.3.1 Company Overview
12.3.3.2 Company Description
12.3.4 Pacific Biosciences of California, Inc.
12.3.4.1 Company Overview
12.3.4.2 Company Description
12.3.5 Beckman Coulter, Inc.
12.3.5.1 Company Overview
12.3.5.2 Company Description
12.3.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global DNA Sequencing Products Market: Key Industry Highlights, 2018 and 2028
2. Global DNA Sequencing Products Historical Market: Breakup by Product Type (USD Billion), 2018-2022
3. Global DNA Sequencing Products Market Forecast: Breakup by Product Type (USD Billion), 2023-2028
4. Global DNA Sequencing Products Historical Market: Breakup by Applications (USD Billion), 2018-2022
5. Global DNA Sequencing Products Market Forecast: Breakup by Applications (USD Billion), 2023-2028
6. Global DNA Sequencing Products Historical Market: Breakup by End Use (USD Billion), 2018-2022
7. Global DNA Sequencing Products Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8. Global DNA Sequencing Products Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global DNA Sequencing Products Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America DNA Sequencing Products Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America DNA Sequencing Products Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe DNA Sequencing Products Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe DNA Sequencing Products Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific DNA Sequencing Products Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific DNA Sequencing Products Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America DNA Sequencing Products Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America DNA Sequencing Products Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa DNA Sequencing Products Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa DNA Sequencing Products Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global DNA Sequencing Products Market Structure
In 2020, the global DNA sequencing products market attained a value of nearly USD 4.6 billion.
The market is projected to grow at a CAGR of 15% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 10.6 billion by 2026.
The major drivers of the industry, such as increasing use in the farming activities, rising demand for improved nutritional value, and growing technological advancements are expected to aid the market growth.
The key market trend guiding the growth of the DNA sequencing products market include the growing use of the product in the in-vitro diagnostics industry, along with increasing investments into R&D activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Consumables and reagents, and equipment are the major product types of DNA sequencing products in the industry.
Biomarkers, diagnostics, reproductive health, forensics, and personalised medicine, among others, are the significant applications of DNA sequencing products.
Academic and government research institutes, pharmaceutical and biotechnology companies, and hospitals and clinics, among others, are the major end-uses of the product.
The major players in the industry are Illumina Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., and Beckman Coulter, Inc., among others.
The global DNA sequencing products market attained a value of USD 4.6 billion in 2020, driven by the rising demand for nutritionally advanced products. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 15%. The market is projected to reach USD 10.6 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the DNA sequencing products industry can be segmented into consumables and reagents, and equipment. On the basis of applications, the industry is divided into biomarkers, diagnostics, reproductive health, forensics, personalized medicine, and others. On the basis of end uses, the industry is categorised into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. The major regional markets for DNA sequencing products are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., Beckman Coulter, Inc., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.